Abstract
Treatment of newly diagnosed immune thrombocytopenia (ITP) is controversial and guidelines vary internationally. At the Paediatric Department, Aalborg Hospital, a "watchful waiting" approach was adopted in the early 2000s. We aimed to investigate whether this change in strategy had any adverse effects on the subsequent clinical outcomes.
Originalsprog | Engelsk |
---|---|
Vol/bind | 58 |
Sider (fra-til) | A4252 |
Status | Udgivet - 2011 |
Udgivet eksternt | Ja |